NEW YORK (Reuters Health) – For patients with type 2 diabetes not controlled with metformin and a sulfonylurea, the choice of an additional agent should be based on…
NEW YORK (Reuters Health) – In patients with impaired renal function, the type of nonionic contrast agent used for coronary angiography seems to make little difference to the…
NEW YORK (Reuters Health) – Neonates with arterial ischemic stroke are at increased risk for having at least one seizure in the following months, but this may not…
The 2011 Society of Hospital Medicine Conference in Dallas, TX, concluded today. The day kicked off with a lecture by Dr. Bradley Sharpe about teaching on the wards.…
NEW YORK (Reuters Health) – Cotreatment with an angiotensin-converting enzyme (ACE) inhibitor reduces the risk of diabetes associated with beta blocker treatment, according to a report in the…
NEW YORK (Reuters Health) – In a phase 2 study of patients with diabetic macular edema (DME), intravitreal injections of the vascular endothelial growth factor inhibitor, VEGF Trap-Eye,…
NEW YORK (Reuters Health) – In patients with left main coronary artery disease (CAD) and acute coronary syndrome (ACS), percutaneous coronary intervention (PCI) is a safe option that…
NEW YORK (Reuters Health) – For women with anorexia nervosa, weekly risedronate increases spinal bone mineral density over the course of a year. Adding low-dose testosterone does not…
NEW YORK (Reuters Health) – In terms of quality of life for patients with COPD, the improvements in lung function and exacerbation frequency produced by phosphodiesterase 4 (PDE4)…
NEW YORK (Reuters Health) – Percutaneous coronary intervention with bare metal stents followed by a course of oral prednisone at immunosuppressive strength produces results comparable to that obtained…
The 2011 Society of Hospital Medicine Conference in Dallas, TX, continued today. The meeting began with an address by Dr. Glenn Rosenbluth and colleagues about the best of…
